Does EPOPROSTENOL Cause Stent placement? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Stent placement have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.2% of all adverse event reports for EPOPROSTENOL.
26
Reports of Stent placement with EPOPROSTENOL
0.2%
of all EPOPROSTENOL reports
2
Deaths
25
Hospitalizations
How Dangerous Is Stent placement From EPOPROSTENOL?
Of the 26 reports, 2 (7.7%) resulted in death, 25 (96.2%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does EPOPROSTENOL Cause?
Dyspnoea (2,744)
Headache (2,425)
Diarrhoea (2,310)
Nausea (2,016)
Pain in jaw (1,928)
Death (1,362)
Flushing (1,256)
Fatigue (1,133)
Hospitalisation (1,078)
Vomiting (1,068)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which EPOPROSTENOL Alternatives Have Lower Stent placement Risk?
EPOPROSTENOL vs EPTIFIBATIDE
EPOPROSTENOL vs EPTINEZUMAB-JJMR
EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR
EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2
EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN